Detalhe da pesquisa
1.
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020.
Euro Surveill
; 25(32)2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32794443
2.
Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic.
Euro Surveill
; 25(46)2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33213683
3.
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.
Euro Surveill
; 25(9)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156327
4.
Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019.
Euro Surveill
; 24(9)2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862331
5.
Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022-2032.
Bull World Health Organ
; 100(4): 239-239A, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35386562
6.
Investing in health preparedness, response and resilience: a genomics costing tool focused on next generation sequencing.
Front Public Health
; 12: 1404243, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38784596
7.
Strengthening pathogen genomic surveillance for health emergencies: insights from the World Health Organization's regional initiatives.
Front Public Health
; 11: 1146730, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37361158
8.
The community impact of the 2009 influenza pandemic in the WHO European region: a comparison with historical seasonal data from 28 countries.
BMC Infect Dis
; 12: 36, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22325082
9.
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
Antiviral Res
; 200: 105281, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292289
10.
Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
Vaccine
; 38(35): 5707-5717, 2020 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32624252
11.
Alternating patterns of seasonal influenza activity in the WHO European Region following the 2009 pandemic, 2010-2018.
Influenza Other Respir Viruses
; 14(2): 150-161, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31944604
12.
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018.
Antiviral Res
; 175: 104718, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32004620
13.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017.
Antiviral Res
; 157: 38-46, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981793
14.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.
Antiviral Res
; 146: 12-20, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28802866
15.
Improving the representativeness of influenza viruses shared within the WHO Global Influenza Surveillance and Response System.
Influenza Other Respir Viruses
; 10(2): 68-75, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589132
16.
Leveraging Global Influenza Surveillance and Response System for the COVID-19 Pandemic Response and Beyond.
China CDC Wkly
; 3(44): 937-940, 2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34745695
17.
The potential risks and impact of the start of the 2015-2016 influenza season in the WHO European Region: a rapid risk assessment.
Influenza Other Respir Viruses
; 10(4): 236-246, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26918771
18.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.
Antiviral Res
; 132: 178-85, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27265623
19.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.
Antiviral Res
; 117: 27-38, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25721488
20.
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.
Antiviral Res
; 110: 31-41, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043638